Associated Papers
Corrigendum to "A novel missense mutation Smad4 V354L enhances the efficacy of docetaxel in non-small cell lung cancer" [Biomed. Pharmacother. 184 (2025) 117899].
Xue X et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie, 2025
A novel missense mutation Smad4 V354L enhances the efficacy of docetaxel in non-small cell lung cancer.
Xue X et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie, 2025
Monitoring of cancer patients via next-generation sequencing of patient-derived circulating tumor cells and tumor DNA.
Onidani K et al.
Cancer Science, 2019
Highly Concordant Key Genetic Alterations in Primary Tumors and Matched Distant Metastases in Differentiated Thyroid Cancer.
Sohn SY et al.
Thyroid : Official Journal of the American Thyroid Association, 2016
Next-generation sequencing of tyrosine kinase inhibitor-resistant non-small-cell lung cancers in patients harboring epidermal growth factor-activating mutations.
Masago K et al.
Bmc Cancer, 2015
Select a paper to view details